DK1581307T3 - Irs modulatorer - Google Patents

Irs modulatorer Download PDF

Info

Publication number
DK1581307T3
DK1581307T3 DK03808631.0T DK03808631T DK1581307T3 DK 1581307 T3 DK1581307 T3 DK 1581307T3 DK 03808631 T DK03808631 T DK 03808631T DK 1581307 T3 DK1581307 T3 DK 1581307T3
Authority
DK
Denmark
Prior art keywords
irs
modulators
irs modulators
Prior art date
Application number
DK03808631.0T
Other languages
English (en)
Inventor
Morris F White
Gerard M Housey
Original Assignee
Gerard M Housey
Morris F White
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerard M Housey, Morris F White filed Critical Gerard M Housey
Application granted granted Critical
Publication of DK1581307T3 publication Critical patent/DK1581307T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
DK03808631.0T 2003-01-02 2003-12-31 Irs modulatorer DK1581307T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43737703P 2003-01-02 2003-01-02
PCT/US2003/041745 WO2004060316A2 (en) 2003-01-02 2003-12-31 Irs modulators

Publications (1)

Publication Number Publication Date
DK1581307T3 true DK1581307T3 (da) 2015-01-05

Family

ID=32713177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03808631.0T DK1581307T3 (da) 2003-01-02 2003-12-31 Irs modulatorer

Country Status (7)

Country Link
US (5) US8557512B2 (da)
EP (2) EP2826484A1 (da)
AU (1) AU2003303520A1 (da)
CA (1) CA2515518A1 (da)
DK (1) DK1581307T3 (da)
ES (1) ES2526695T3 (da)
WO (1) WO2004060316A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120034649A (ko) * 2009-05-11 2012-04-12 버그 바이오시스템즈, 엘엘씨 환경대사적 전환인자（조효소 ｑ１０）를 사용한 질환의 치료 방법
KR101703695B1 (ko) * 2009-05-22 2017-02-08 큐알엔에이, 인크. 전사 인자 ｅ3(ｔｆｅ3)에 대한 천연 안티센스 전사체의 억제에 의해 ｔｆｅ3 및 인슐린 수용체 기질 2(ｉｒｓ2)의 치료
US20120289583A1 (en) * 2009-12-31 2012-11-15 Curna, Inc. Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
ES2762451T3 (es) 2011-04-04 2020-05-25 Berg Llc Tratamiento de tumores del sistema nervioso central con coenzima Q10
KR101259342B1 (ko) * 2011-07-14 2013-05-06 경상대학교산학협력단 비만 예방 또는 치료제의 스크리닝 방법
JP2016514146A (ja) * 2013-03-12 2016-05-19 エイチエムアイ・メディカル・イノヴェイションズ・エルエルシー 抗糖尿病及び他の有用な活性を有する植物抽出物
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムｑ１０の連続注入によるがんの治療方法
CA3063110A1 (en) 2017-05-12 2018-11-15 Housey Pharmaceutical Research Laboratories, L.L.C. Plant extracts with anti-diabetic and other useful activities

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688655A (en) * 1988-02-10 1997-11-18 Ict Pharmaceuticals, Inc. Method of screening for protein inhibitors and activators
US5266464A (en) * 1988-02-10 1993-11-30 Ict Pharmaceuticals, Inc. Method of screening for protein inhibitors and activators
US5260200A (en) * 1991-01-18 1993-11-09 Joslin Diabetes Center, Inc. Isolated DNA encoding an insulin receptor substrate
US5858701A (en) * 1994-10-03 1999-01-12 Joslin Diabetes Center, Inc. DNA encoding an insulin receptor substrate
DE19921537A1 (de) * 1999-05-11 2000-11-23 Dieter Hoersch Verfahren zur Induzierung von Zellwachstum durch Verwendung geeigneter Mittel
US20010012829A1 (en) * 2000-01-11 2001-08-09 Keith Anderson Transepithelial delivery GLP-1 derivatives
SE0002189D0 (sv) * 2000-06-09 2000-06-09 Metcon Medicin Ab New method and assay

Also Published As

Publication number Publication date
US20190046615A1 (en) 2019-02-14
US20060241030A1 (en) 2006-10-26
AU2003303520A1 (en) 2004-07-29
US20140243398A1 (en) 2014-08-28
AU2003303520A8 (en) 2004-07-29
EP1581307B1 (en) 2014-09-24
US8557512B2 (en) 2013-10-15
ES2526695T3 (es) 2015-01-14
US20170035857A1 (en) 2017-02-09
EP2826484A1 (en) 2015-01-21
US20200405817A1 (en) 2020-12-31
EP1581307A2 (en) 2005-10-05
WO2004060316A3 (en) 2005-04-21
WO2004060316A2 (en) 2004-07-22
EP1581307A4 (en) 2009-02-11
CA2515518A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
ATE456558T1 (de) Gabanerge modulatoren
DE502004002833D1 (de) Alkoxysilanterminierte prepolymere
DE602004026540D1 (de) Kurbelwellenmomentmodulator
DE602004030335D1 (de) Optisches element
ATE363383T1 (de) Schlingenware
NO20054198D0 (no) Sentrifugalkompressorenhet
DK2447252T3 (da) Theramuteinmodulatorer
DE112004000620D2 (de) Struktoguss
DE502004000672D1 (de) Pigmentpreparationen
DE602004013234D1 (de) Elektrooptisches Element
DE602004019259D1 (de) Optischer Kollimator
DK1581307T3 (da) Irs modulatorer
DE602004018247D1 (de) Modulator
ATE446959T1 (de) Chromenonindole
DE502004002978D1 (de) N-biarylamide
DE602004023646D1 (de) Sammensetzungen
DE502004000518D1 (de) Mitgängergabelhubwagen
NO20033191D0 (no) Fargemodulator
DE10394329D2 (de) Mäanderstent
DE10355350A8 (de) Elektromodul
ATE406350T1 (de) Prolinylarylacetamide
DE112004002227D2 (de) Nietverarbeitungsgerät
DE602005025498D1 (de) Optischer fsk-modulator
DE10329218B4 (de) Hotflue
DE502004002619D1 (de) Flaschenverschluss